OSCR
Oscar Health, Inc. · Healthcare · Medical - Healthcare Plans
Momentum inputs (comparable managers):
holder breadth -6.2% ·
share flow -13.0% ·
net new positions -6.7%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 2.63M | $81.23M | n/a | n/a |
| Q2 2026 | 123 | +14 | 137.19M | $3.91B | +21 | −6 |
| Q1 2026 | 111 | -1 | 110.57M | $1.27B | +11 | −13 |
| Q4 2025 | 112 | -3 | 121.38M | $1.74B | +2 | −4 |
| Q3 2025 | 22 | +3 | 74.59M | $1.41B | +5 | −3 |
| Q2 2025 | 17 | -1 | 57.51M | $1.23B | +1 | −2 |
| Q1 2025 | 15 | -1 | 25.41M | $333.18M | +2 | −3 |
| Q4 2024 | 16 | -1 | 29.22M | $392.74M | +2 | −3 |
| Q3 2024 | 16 | +2 | 34.05M | $722.32M | +2 | n/a |
| Q2 2024 | 14 | n/a | 28.60M | $452.40M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 5.78M | -2.2% | $75.83M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 4.68M | +4.8% | $61.43M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Capital World Investors ✦ | 3.62M | 0.0% | $47.49M | 0.0% | Held | 4 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 3.33M | -29.9% | $43.60M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 2.18M | +8.4% | $28.59M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.48M | +245.3% | $19.41M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 952.57K | -64.4% | $12.49M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 822.09K | 0.0% | $10.78M | 0.0% | Held | 4 | SEC ↗ |
| 9 | Glenview Capital ✦ | 798.98K | New | $10.47M | 0.3% | New | 1 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 721.92K | +2.0% | $9.46M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 513.26K | New | $6.73M | 0.0% | New | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 295.49K | +139.9% | $3.87M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 203.13K | -29.8% | $2.66M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 14 | Norges Bank ✦ (passive) | 16.72K | -79.3% | $219,173 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 11.69K | +16.5% | $153,269 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Glenview Capital | $10.47M | 0.3% |
| Adage Capital Partners | $6.73M | 0.0% |
Exited
| Viking Global Investors | $41.31M | was 0.1% |
| Scion Asset Management | $2.69M | was 3.5% |
| Marshall Wace | $596,736 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 84.20K shares, $965 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 25.00K sh · $806,000
Officer · 958 sh · $30,129
Officer · 10.36K sh · $325,822
Officer · 9.09K sh · $285,943
Director · 31.42K sh · $988,222
Officer · 28.87K sh · $907,930
Director · 150.00K sh · $4.62M
Director · 600.00K sh · $18.20M
Officer · 18.75K sh · $595,125
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
1.7% of class · View original SEC filing ↗